Lyell Immunopharma, Inc. (LYEL)
22.71
+0.07
(+0.31%)
USD |
NASDAQ |
Feb 06, 16:00
22.72
+0.02
(+0.07%)
After-Hours: 20:00
Lyell Immunopharma SG&A Expense (TTM) : 49.04M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 631.20M |
| Nektar Therapeutics | 74.62M |
| GT Biopharma, Inc. | 6.564M |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |